bci test breast cancer

Release time ：Dec-19,2024

The Breast Cancer Index (BCI) test is a medical assessment tool designed to evaluate the risk of recurrence in breast cancer patients. It forecasts the likelihood of cancer relapse by analyzing specific proteins and molecular markers within the patient's tumor cells.

During the BCI test, physicians extract cells from the patient’s tumor tissue and perform a battery of biochemical and molecular biology analyses. These analyses aid in understanding the characteristics of tumor cell proliferation and metastasis, thus enabling a more precise estimation of the patient's risk of recurrence.

Results from the BCI test are typically expressed as a score, with higher scores signifying a higher risk of recurrence. However, it is important to recognize that the BCI test is not an infallible diagnostic instrument; its outcomes serve as one of several references for physicians when devising treatment plans. Consequently, after receiving the BCI test results, patients should engage in thorough discussions with their healthcare providers to determine the most appropriate therapeutic strategy tailored to their individual needs.